November 27, 2014 10:03 pm | Updated 10:03 pm IST - MUMBAI:
Cipla and Strides Arcolab on Thursday signed collaboration agreements with Medicines for Malaria Venture (MMV) for the development of rectal artesunate for pre-referral treatment of children with severe malaria.
A joint statement from Cipla and MMV said the collaborations, established under the MMV-led ‘Improving severe malaria outcomes’ project funded by UNITAID, aim to develop a rectal artesunate product for submission to the World Health Organization (WHO) pre-qualification.
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
